Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELRANATAMAB-BCMM vs ELVITEGRAVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELRANATAMAB-BCMM vs ELVITEGRAVIR: Safety Overview

Metric ELRANATAMAB-BCMM ELVITEGRAVIR
Total FAERS Reports 570 211
Deaths Reported 120 8
Death Rate 21.1% 3.8%
Hospitalizations 168 33
Average Patient Age 69.5 yrs 42.4 yrs
% Female Patients 49.4% 38.8%
FDA Approval Date N/A Sep 24, 2014
Marketing Status N/A Discontinued